Chemoprevention Clinical Trial of COVID-19: Hydroxychloroquine Post Exposure Prophylaxis
Condition: SARS-CoV Infection Intervention: Drug: hydroxychloroquine Sponsors: Regional Center for Disease Control and Prevention, Jordan; Farhat Hached Hospital, Tunisia; Fattouma Bourguiba, Tunisia Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials